Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet

Group 1 - Mersana Therapeutics, Inc. (MRSN) closed at $8.11, with a potential upside of 248.8% based on a mean price target of $28.29 set by Wall Street analysts [1] - The mean estimate includes seven short-term price targets with a standard deviation of $16.09, indicating variability among analysts; the lowest estimate is $8.00 (1.4% decline), while the highest is $50.00 (516.5% increase) [2] - Analysts show strong agreement on MRSN's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] Group 2 - Over the last 30 days, three earnings estimates for MRSN have been revised higher, leading to a 92.8% increase in the Zacks Consensus Estimate [12] - MRSN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [14]